Sig Brokerage »

Crispr Therapeutics shares owned by Sig Brokerage

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Sig Brokerage from 13F filings

Historical chart of Sig Brokerage investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Sig Brokerage consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Sig Brokerage

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1M 16k 64.81

More positions owned by Sig Brokerage

Meta Platforms Cl A Put Option (META)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Oracle Corporation (ORCL)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation Put Option (MSFT)
Tesla Motors (TSLA)
Apollo Global Mgmt Call Option (APO)
Booking Holdings (BKNG)
Ishares Msci Brazil Etf (EWZ)
Arm Holdings Sponsored Ads Call Option (ARM)
Coreweave Com Cl A (CRWV)
Thermo Fisher Scientific Call Option (TMO)
Spdr Gold Tr Gold Shs Put Option (GLD)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
UnitedHealth Put Option (UNH)

View all positions for Sig Brokerage

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Capital Research and Management Company - Division 3
Orbis Allan Gray
State Street Corporation
T. Rowe Price Investment Management
UBS Group
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Geode Capital Management
Susquehanna International
Sr One Capital Management
Citadel Advisors
FMR

View all funds holding Crispr Therapeutics